Brief: Merck Highlights New Long-Term Data And Advancements Across Broad Oncology Portfolio And Pipeline Research At Asco 2026
12/05/2026 11:45
May 12 (Reuters) - Merck & Co Inc MRK.N: MERCK HIGHLIGHTS NEW LONG-TERM DATA AND ADVANCEMENTS ACROSS BROAD ONCOLOGY PORTFOLIO AND PIPELINE RESEARCH AT ASCO 2026 Source text: ID:nBw7dcKPGa Further company coverage: MRK.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Merck & Co
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials